Loading...
Loading...
HOLX| Name | Value |
|---|---|
| Revenues | 1,049.5M |
| Cost of Revenue | 466.0M |
| Gross Profit | 583.5M |
| Operating Expense | 346.5M |
| Operating I/L | 237.0M |
| Other Income/Expense | -9.7M |
| Interest Income | 19.0M |
| Pretax | 227.4M |
| Income Tax Expense | 40.1M |
| Net Income/Loss | 187.3M |
Hologic, Inc. is a leading provider of diagnostics products, medical imaging systems, and surgical products for women's health globally. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its offerings include molecular diagnostic assays for infectious microorganisms, viral load tests for HIV and Hepatitis, SARS-CoV-2 detection assays, breast imaging systems, minimally invasive breast biopsy guidance systems, endometrial ablation and hysteroscopic tissue removal systems, and dual energy X-ray systems for skeletal health. Hologic generates revenue through direct sales, service forces, and independent distributors, catering to the early detection and treatment needs in women's health.
